Literature DB >> 18355888

Systemic and mucosal immunological responses during repeated mucosal SHIV(162P3) challenges prior to and following infection in pigtailed macaques.

Nattawan Promadej-Lanier1, Priya Srinivasan, Kelly Curtis, Debra R Adams, Caryn Kim, Wei Luo, Hongwei Jia, Shambavi Subbarao, Ron A Otten, Sal Butera.   

Abstract

Local and systemic immunological changes following vaginal HIV-1 exposures are poorly characterized and may influence susceptibility to infection. Therefore, we examined longitudinal mucosal, plasma cytokine profiles and viral-specific T-cell responses (vSTRs) before and during weekly repeated low-dose SHIV(SF162P3) viral challenges in six female pigtailed macaques, even in the absence of overt systemic infection. Following a single viral challenge, induction of several cytokines was detected consistently in cervico-vaginal lavages (CVL). With additional exposure and documented systemic infection, a hallmark of response profile was defined as peak levels in both CVL (MCP-1, MIP-1alpha, TNF-alpha, IL-1beta, IL-1RA and IL-8) and plasma cytokines (MCP-1, eotaxin and IL-1RA) in the macaques. In the periphery, vSTRs were observed within the first one or two viral challenges, but prior to the detection of systemic infection in 5/6 exposed pigtailed macaques. These findings provide valuable information regarding mucosal HIV-1 infection that may benefit microbicide research and development.

Entities:  

Mesh:

Substances:

Year:  2008        PMID: 18355888     DOI: 10.1016/j.virol.2008.01.040

Source DB:  PubMed          Journal:  Virology        ISSN: 0042-6822            Impact factor:   3.616


  15 in total

1.  International multicenter study to assess a panel of reference materials for quantification of simian immunodeficiency virus RNA in plasma.

Authors:  Claire Ham; Priya Srinivasan; Rigmor Thorstensson; Ernst Verschoor; Zahra Fagrouche; Leonardo Sernicola; Artur Ramos; Fausto Titti; Neil Almond; Neil Berry
Journal:  J Clin Microbiol       Date:  2010-04-28       Impact factor: 5.948

2.  Vaccination with peptide mimetics of the gp41 prehairpin fusion intermediate yields neutralizing antisera against HIV-1 isolates.

Authors:  Elisabetta Bianchi; Joseph G Joyce; Michael D Miller; Adam C Finnefrock; Xiaoping Liang; Marco Finotto; Paolo Ingallinella; Philip McKenna; Michael Citron; Elizabeth Ottinger; Robert W Hepler; Renee Hrin; Deborah Nahas; Chengwei Wu; David Montefiori; John W Shiver; Antonello Pessi; Peter S Kim
Journal:  Proc Natl Acad Sci U S A       Date:  2010-05-18       Impact factor: 11.205

3.  Longitudinal assessment of pigtailed macaque lower genital tract microbiota by pyrosequencing reveals dissimilarity to the genital microbiota of healthy humans.

Authors:  Gregory T Spear; Ellen Kersh; Patricia Guenthner; Sundaram Ajay Vishwanathan; Douglas Gilbert; M Reza Zariffard; Paria Mirmonsef; Alan Landay; Luyang Zheng; Patrick Gillevet
Journal:  AIDS Res Hum Retroviruses       Date:  2012-05-03       Impact factor: 2.205

4.  Short communication: Viremic control is independent of repeated low-dose SHIVSF162p3 exposures.

Authors:  Tara R Henning; Debra Hanson; Sundaram A Vishwanathan; Katherine Butler; Charles Dobard; Gerardo Garcia-Lerma; Jessica Radzio; James Smith; Janet M McNicholl; Ellen N Kersh
Journal:  AIDS Res Hum Retroviruses       Date:  2014-10-14       Impact factor: 2.205

5.  Repeated administration of high-dose depot medroxyprogesterone acetate does not alter SHIVSF162p3 viral kinetics and tenofovir pharmacokinetics when delivered via intravaginal rings.

Authors:  Priya Srinivasan; Jining Zhang; Chuong T Dinh; Ryan S Teller; Janet M McNicholl; Patrick F Kiser; Betsy C Herold; James M Smith
Journal:  J Med Primatol       Date:  2017-08       Impact factor: 0.667

6.  Development of a pigtail macaque model of sexually transmitted infection/HIV coinfection using Chlamydia trachomatis, Trichomonas vaginalis, and SHIV(SF162P3).

Authors:  Tara Henning; Yetunde Fakile; Christi Phillips; Elizabeth Sweeney; James Mitchell; Dorothy Patton; Gail Sturdevant; Harlan D Caldwell; W Evan Secor; John Papp; R Michael Hendry; Janet McNicholl; Ellen Kersh
Journal:  J Med Primatol       Date:  2011-08       Impact factor: 0.667

7.  Pharmacokinetics and Preliminary Safety of Pod-Intravaginal Rings Delivering the Monoclonal Antibody VRC01-N for HIV Prophylaxis in a Macaque Model.

Authors:  Chunxia Zhao; Manjula Gunawardana; Francois Villinger; Marc M Baum; Mariana Remedios-Chan; Thomas R Moench; Larry Zeitlin; Kevin J Whaley; Ognian Bohorov; Thomas J Smith; Deborah J Anderson; John A Moss
Journal:  Antimicrob Agents Chemother       Date:  2017-06-27       Impact factor: 5.191

8.  Vaccine targeting SIVmac251 protease cleavage sites protects macaques against vaginal infection.

Authors:  Hongzhao Li; Robert W Omange; Binhua Liang; Nikki Toledo; Yan Hai; Lewis R Liu; Dane Schalk; Jose Crecente-Campo; Tamara G Dacoba; Andrew B Lambe; So-Yon Lim; Lin Li; Mohammad Abul Kashem; Yanmin Wan; Jorge F Correia-Pinto; Michael S Seaman; Xiao Qing Liu; Robert F Balshaw; Qingsheng Li; Nancy Schultz-Darken; Maria J Alonso; Francis A Plummer; James B Whitney; Ma Luo
Journal:  J Clin Invest       Date:  2020-12-01       Impact factor: 14.808

9.  Human herpesvirus 8 glycoprotein B binds the entry receptor DC-SIGN.

Authors:  Heather R Hensler; Monica J Tomaszewski; Giovanna Rappocciolo; Charles R Rinaldo; Frank J Jenkins
Journal:  Virus Res       Date:  2014-07-11       Impact factor: 3.303

10.  An intravaginal ring that releases the NNRTI MIV-150 reduces SHIV transmission in macaques.

Authors:  Rachel Singer; Paul Mawson; Nina Derby; Aixa Rodriguez; Larisa Kizima; Radhika Menon; Daniel Goldman; Jessica Kenney; Meropi Aravantinou; Samantha Seidor; Agegnehu Gettie; James Blanchard; Michael Piatak; Jeffrey D Lifson; José A Fernández-Romero; Melissa Robbiani; Thomas M Zydowsky
Journal:  Sci Transl Med       Date:  2012-09-05       Impact factor: 17.956

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.